Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-022628
Filing Date
2023-03-24
Accepted
2023-03-24 09:11:56
Documents
63
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_raphaelpharma.htm   iXBRL 10-K 1006257
2 CERTIFICATION f10k2022ex31-1_raphael.htm EX-31.1 8113
3 CERTIFICATION f10k2022ex31-2_raphael.htm EX-31.2 8092
4 CERTIFICATION f10k2022ex32-1_raphael.htm EX-32.1 3524
5 CERTIFICATION f10k2022ex32-2_raphael.htm EX-32.2 3312
6 GRAPHIC image_001.jpg GRAPHIC 11404
7 GRAPHIC image_002.jpg GRAPHIC 35097
8 GRAPHIC fin_001.jpg GRAPHIC 2787
9 GRAPHIC fin_002.jpg GRAPHIC 1413
  Complete submission text file 0001213900-23-022628.txt   3955414

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cik0000141539-20221231.xsd EX-101.SCH 52842
11 XBRL CALCULATION FILE cik0000141539-20221231_cal.xml EX-101.CAL 16982
12 XBRL DEFINITION FILE cik0000141539-20221231_def.xml EX-101.DEF 164291
13 XBRL LABEL FILE cik0000141539-20221231_lab.xml EX-101.LAB 354226
14 XBRL PRESENTATION FILE cik0000141539-20221231_pre.xml EX-101.PRE 170184
57 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_raphaelpharma_htm.xml XML 305238
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

EIN.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53002 | Film No.: 23757898
SIC: 2833 Medicinal Chemicals & Botanical Products